Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Internal Medicine
Association Of Glucagon-Like Peptide-1 Receptor Agonist Treatment With Perioperative And Postoperative Complications In Patients Undergoing Elective Bariatric Surgery, Justin Sanchez, Enith Espinosa, Sean Sojdie, Michael Green, Lauren Wonderly
Association Of Glucagon-Like Peptide-1 Receptor Agonist Treatment With Perioperative And Postoperative Complications In Patients Undergoing Elective Bariatric Surgery, Justin Sanchez, Enith Espinosa, Sean Sojdie, Michael Green, Lauren Wonderly
North Texas GME Research Forum 2024
Glucagon-like peptide receptor agonists (GLP-1 RA) are FDA-approved medications for the treatment of type 2 diabetes mellitus, and obesity, and are also beneficial in cardiovascular risk reduction. However, due to known GLP-1 RA adverse effects, notably delayed gastric emptying, the ASA has implemented GLP-1RA guidelines aiming to minimize potential complications related to GLP-1 RA use in patients undergoing procedures requiring general anesthesia. With the ever-increasing number of patients being prescribed GLP-1 RAs, more research needs to be conducted to investigate their potential impact in other areas of healthcare. This retrospective study aims to compare surgical outcomes before and following the …